Skip to main content

Table 4 Outcomes by PVL status

From: Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negative Staphylococcus aureus infections in Western Australia: a case control study

Management or Outcome PVL positive (n = 141) PVL negative (n = 148) p-value
Initial antibiotics effective 75 (53.2) 90 (60.8) 0.191
Lincosamide/linezolid initial Txa 9 (6.4) 4 (2.8) 0.141
Lincosamide/linezolid 3db 29 (20.8) 10 (6.8) <0.001
Surgery performed 103 (73.0) 66 (44.6) <0.001
HDA/ICU admissionc 8 (5.7) 17 (11.5) 0.079
Median length of stay-days (range) 5.0 (0–81) 13.5 (0–638) <0.001
Death within 30 days 4 (2.8) 10 (6.8) 0.121
Death within 1 year 9 (6.4) 29 (19.6) 0.001
  1. aLincosamide or linezolid prescribed in the initial therapy.
  2. bLincosamide or linezolid added to therapy within 3 days of isolate collection.
  3. cHigh dependency area or intensive care unit admission.
  4. Number (%).